REGN vs. ILMN: Which Stock Is the Better Value Option?

Core Viewpoint - The analysis compares Regeneron (REGN) and Illumina (ILMN) to determine which stock offers better value for investors in the Medical - Biomedical and Genetics sector [1] Group 1: Zacks Rank and Earnings Outlook - Regeneron has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook compared to Illumina, which has a Zacks Rank of 3 (Hold) [3] - REGN is noted for its improving earnings outlook, making it a standout in the Zacks Rank model [7] Group 2: Valuation Metrics - REGN has a forward P/E ratio of 18.07, while ILMN has a higher forward P/E of 29.18 [5] - The PEG ratio for REGN is 1.81, compared to ILMN's PEG ratio of 2.46, indicating REGN may be undervalued relative to its expected earnings growth [5] - REGN's P/B ratio is 2.64, significantly lower than ILMN's P/B of 9.44, further supporting REGN's valuation as more attractive [6] - These metrics contribute to REGN's Value grade of B and ILMN's Value grade of C [6]